Gabapentinoids linked to increased risk for severe exacerbation in COPD
Jan 16, 2024
Compared with matched nonusers, gabapentinoid users have an increased risk across indications of epilepsy, neuropathic pain and other chronic pain.
FDA finds no evidence linking Wegovy, Ozempic to suicidal behaviors
Jan 12, 2024
The agency, however, noted that officials cannot rule out that “a small risk may exist,” and said it will continue to investigate.
Statin initiation cuts mortality in older adults with chronic kidney disease
Jan 05, 2024
The findings were seen among older adults with stage 3 to 4 disease with no prior atherosclerotic cardiovascular disease.
FDA allows Florida to import cheaper drugs from Canada
Jan 05, 2024
The plan would let Florida buy selected drugs in bulk from Canada, following FDA review.
Nirmatrelvir during acute SARS-CoV-2 does not reduce risk for long COVID
Jan 05, 2024
No association was seen for rebound symptoms or test positivity with symptoms of long COVID.
Warfarin cuts mortality, thromboembolism after valve replacement
Jan 04, 2024
Warfarin, however, was tied to an increased risk for major bleeding events.
One in eight older adults reports using cannabis in past year
Dec 28, 2023
Use was more likely among unmarried or unpartnered adults and those consuming alcohol.
Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D
Dec 27, 2023
Dapagliflozin, however, does not reduce the urinary albumin-to-creatinine ratio in those patients.
Company seeks FDA approval for MDMA as treatment for PTSD
Dec 13, 2023
“If approved, MDMA-assisted therapy would be the first psychedelic-assisted therapy, which we hope will drive additional investment into new research in mental health.”
New poll finds older Americans believe Medicare should cover weight-loss drugs
Dec 13, 2023
A 2003 law currently prohibits Medicare from covering medications specifically for weight loss. The poll was among those aged 50 to 80.
